AMLX
Amylyx Pharmaceuticals, Inc. Common Stock#10 · 2022EPBYearly return
+105%
Peak return
+120%
Max drawdown
-81%
ADR (20 days)
+5.4%
Base
36 days / -47.0%
Prior run
+18%
Breakout volume
99.5x
Pivot
$10.15
Catalyst Earnings/Guidance2022-06-06Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 UpdateSeeking Alpha
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare AMLX with the current market directly.